Mario Angelico
Mario Angelico
Full Professor of Gastroenterology, Tor Vergata University
Verified email at
Cited by
Cited by
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ...
Gastroenterology 150 (5), 1147-1159. e5, 2016
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV‐related cirrhosis
M Angelico, D Di Paolo, MO Trinito, A Petrolati, A Araco, S Zazza, ...
Hepatology 35 (1), 176-181, 2002
Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis
M Angelico, L Carli, C Piat, S Gentile, L Capocaccia
Gastroenterology 113 (5), 1632-1639, 1997
Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections
M Angelico, E Renganathan, C Gandin, M Fathy, MC Profili, W Rafai, ...
Journal of hepatology 26 (2), 236-243, 1997
Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis
M Angelico, L Carli, C Piat, S Gentile, V Rinaldi, E Bologna, L Capocaccia
Gastroenterology 104 (5), 1460-1465, 1993
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence
G Tisone, G Orlando, A Cardillo, G Palmieri, TM Manzia, L Baiocchi, ...
Journal of hepatology 44 (4), 702-709, 2006
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha
G Alpini, L Baiocchi, S Glaser, Y Ueno, M Marzioni, H Francis, JL Phinizy, ...
Hepatology 35 (5), 1041-1052, 2002
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
P Piccolo, I Lenci, L Demelia, F Bandiera, MR Piras, G Antonucci, ...
Antivir Ther 14 (8), 1165-74, 2009
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ...
The Lancet 391 (10138), 2417-2429, 2018
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
M Angelico, A Petrolati, R Lionetti, I Lenci, P Burra, MF Donato, M Merli, ...
Journal of hepatology 46 (6), 1009-1017, 2007
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors
V Cento, C Mirabelli, R Salpini, S Dimonte, A Artese, G Costa, F Mercurio, ...
PloS one 7 (7), e39652, 2012
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression
R Salpini, L Colagrossi, MC Bellocchi, M Surdo, C Becker, C Alteri, ...
Hepatology 61 (3), 823-833, 2015
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation
G Tisone, M Angelico, G Palmieri, F Pisani, A Anselmo, L Baiocchi, ...
Transplantation 67 (10), 1308-1313, 1999
Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience
A Orlacchio, G Bazzocchi, D Pastorelli, F Bolacchi, M Angelico, ...
Cardiovascular and interventional radiology 31 (3), 587-594, 2008
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late
AM Pellicelli, M Montalbano, R Lionetti, C Durand, P Ferenci, G D’Offizi, ...
Digestive and Liver Disease 46 (10), 923-927, 2014
Structural alterations in lecithin-cholesterol vesicles following interactions with monomeric and micellar bile salts: physical-chemical basis for subselection of biliary …
DE Cohen, M Angelico, MC Carey
Journal of Lipid Research 31 (1), 55-70, 1990
Switch to 1.5 grams MMF monotherapy for CNI‐related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension
G Orlando, L Baiocchi, A Cardillo, G Iaria, N De Liguori, L De Luca, ...
Liver transplantation 13 (1), 46-54, 2007
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence
I Lenci, G Tisone, D Di Paolo, F Marcuccilli, L Tariciotti, M Ciotti, V Svicher, ...
Journal of hepatology 55 (3), 587-593, 2011
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease
D Alvaro, P Onori, G Alpini, A Franchitto, DM Jefferson, A Torrice, ...
The American journal of pathology 172 (2), 321-332, 2008
The system can't perform the operation now. Try again later.
Articles 1–20